
Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Human epidermal growth factor receptor 2; Nanoparticle albumin-bound paclitaxel; Neoadjuvant chemotherapy; Pathologic complete response; Trastuzumab